関連する実験動画
Updated: Sep 10, 2025

08:04
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
3.0K
リスク集団における臓がんにおける経路特異性ゲノム変異
Cecilia Monge1, Brigette Waldrup2, Francisco G Carranza2
1Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
International journal of molecular sciences
|August 28, 2025
まとめ
ヒスパニック/ラテン系臓がん患者はTGF-Betaのような重要な経路に 独特の遺伝子変異を示し,SMAD2やERBB4のような特定の遺伝子はより頻繁です. これらの発見は,民族特有の精密腫瘍学の必要性を強調しています.
科学分野:
- ゲノミクス
- 腫瘍学
- 健康 の 格差
背景:
- 臓がん (PC) は攻撃的で,生存率が低いため,後期に診断されたヒスパニック系/ラテン系 (H/L) の患者は不均衡に罹患しています.
- PCの結果におけるこれらの民族的差異を駆動する分子メカニズムはよく理解されていません.
- 主要な腫瘍発生経路 (TP53,WNT,PI3K,TGF-Beta,RTK/RAS) は,がんにおいて頻繁に変化する.
研究 の 目的:
- H/Lと非ヒスパニック・ホワイト (NHW) の臓がん患者の主要な発がん経路の変異を特徴づけ,比較する.
- 臓がんに影響を与える 民族特有の分子差異を調査する.
- 経路の変化と生存結果の関連性を探求する.
主な方法:
- 4248人の臓がん患者 (407 H/L,3841 NHW) の公開されたゲノムデータを分析した.
- TP53,WNT,PI3K,TGF-Beta,RTK/RAS経路における突然変異の頻度の比較は,Chi2テストを用いて行われました.
- 経路の変化に基づく生存差を評価するためのカプラン・マイヤー分析
主要な成果:
- TGF-Beta経路の変異は,H/ L患者 (18. 4%) とNHW患者 (24. 4%) と比較して,特にSMAD2とSMAD4の差異があった.
- SMAD2の変異はH/ L患者でより頻繁に見られた (1. 5% 対 0. 4%),SMAD4の変異はより少なく見られた (15% 対 19. 9%).
- ERBB4,ALK,HRAS,RIT1 (RTK/RAS) とCTNNB1 (WNT) の遺伝子は,H/ L患者でより高い頻度で,境界線上の有意な差異を示した.
結論:
- H/ L患者では,SMAD2,ERBB4,ALK,CTNNB1の変異が増加している.
- SMAD4とPI3K経路の変化は,特にNHW患者で予後効果を示した.
- 発見は,臓がんの精密腫瘍学戦略に民族特有の分子プロファイルの統合の必要性を強調しています.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K

